Back pain (patient information)
For the main WikiDoc page, see Back pain.
|
Back pain Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Lecture |
|
Case Studies |
|
Back pain (patient information) On the Web |
|
American Roentgen Ray Society Images of Back pain (patient information) |
|
Risk calculators and risk factors for Back pain (patient information) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Patient education should accompany initial management of mechanical or nonspecific low back pain at any symptom duration. Core counseling comprises reassurance after assessment for serious pathology, realistic recovery expectations, encouragement to remain active, and practical self-management advice. Provide brief written material to reinforce verbal counseling.[1][2]
This guidance applies to adults. A systematic review identified no high-quality clinical practice guidelines for people younger than 16 years; evidence to guide extrapolation of adult recommendations to children and adolescents is therefore limited.[3] Treatment decisions should consider patient preferences, availability, potential harms, and costs.[4]
In a meta-analysis of randomized trials, primary care-based patient education improved reassurance compared with usual care or control education, with moderate-certainty evidence, and reduced primary care visits for low back pain at 1 year. It did not reduce pain intensity. Education should validate symptoms while addressing misconceptions about spinal fragility and the relationship between pain and tissue damage.[5][6]
Explaining pain and symptom duration
Most nonspecific low back pain does not indicate serious disease. Pain is real, but its intensity does not reliably indicate the extent of tissue injury. Avoid attributing symptoms to an unconfirmed structural lesion or describing the spine as fragile.[1]
Persistent pain may involve increased nervous-system sensitivity rather than continuing tissue injury. Emphasize achievable improvements in function, participation, and self-management even when pain remains.[1][6]
For consistency, the recovery terminology below uses acute pain lasting less than 6 weeks, subacute pain lasting 6–12 weeks, and chronic pain lasting more than 12 weeks. Other guidelines use different boundaries; ACP defines acute pain as lasting less than 4 weeks.[1][4]
Safety-net counseling
Reassurance applies to the assessed presentation and should not discourage reporting new or changing symptoms. Explain which symptoms require emergency assessment and when to arrange reassessment if recovery is delayed.[7][8]
Immediate emergency assessment
- New urinary retention, difficulty starting urination, reduced sensation of urine flow, new loss of bladder or bowel control, altered saddle/genital/perianal sensation, new sexual dysfunction, sciatica-type leg pain with these features, or severe or progressive leg weakness accompanying back pain may indicate cauda equina syndrome.[9] New bilateral leg symptoms are an additional warning feature, particularly when accompanied by bladder, bowel, sensory, or motor changes.[10]
- Back pain with abdominal pain or a suspected pulsatile abdominal mass requires emergency assessment for possible abdominal aortic aneurysm, particularly in older people with a smoking history.[7]
Urgent medical assessment
- Urgent same-day medical assessment: fever accompanying back pain, particularly with immunosuppression, intravenous drug use, recent infection, an indwelling catheter or central line, or a recent spinal procedure, warrants assessment for spinal infection, including epidural abscess. Associated neurologic deficits require emergency assessment.[7][8]
- Urgent assessment; emergency assessment if neurologic symptoms are present: new severe back pain in someone taking anticoagulants warrants urgent assessment. New neurologic symptoms require emergency assessment.[8]
The same-day timeframe for suspected spinal infection is a pragmatic safety-netting recommendation based on clinical urgency rather than a validated diagnostic threshold.
Prompt medical assessment or reassessment
- Significant trauma, or new pain after minor trauma in someone aged 75 years or older, with osteoporosis, or with chronic corticosteroid exposure, warrants assessment for fracture. Younger athletes with risk factors for stress fracture, including relative energy deficiency in sport, also warrant assessment.[7]
- New or worsening pain with a cancer history, unexplained weight loss, new onset after age 50, or failure to improve after about 1 month warrants reassessment. Age and delayed improvement require interpretation in context; neither establishes malignancy individually.[7]
Detailed red-flag interpretation, diagnostic testing, and emergency management are addressed in the differential diagnosis and diagnostic microchapters.
Explaining clinical assessment and imaging
Explain that assessment begins with the clinical history and physical examination; further testing depends on the findings and suspicion of underlying pathology.[7]
Routine imaging is not recommended without indications of serious pathology, and early imaging does not improve outcomes. Imaging that is not indicated has been associated with more injections, surgery, and disability compensation.[11]
Degenerative findings are common without pain: estimated disc degeneration prevalence increases from 37% at age 20 to 96% at age 80, and disc bulge prevalence from 30% to 84%, respectively. These findings do not automatically explain symptoms.[12]
Treatment counseling
Most nonspecific low back pain does not require surgery or injections; treatment selection is addressed in the medical therapy and procedural therapy microchapters.[1][6]
Activity and self-management
Encourage continuation or gradual resumption of usual activities and work, with pacing according to symptoms and functional goals. Prolonged bed rest is discouraged.[2][13]
- Activity pacing: support a graded return to meaningful activities rather than prolonged avoidance. Agree on functional goals, including usual daily roles and work participation.[2][13]
- Symptom relief: superficial heat is a short-term option for acute or subacute pain. ACP reports moderate-quality evidence of improvement in pain and function; skin flushing may occur. Evidence is insufficient for heat in chronic pain and for cold therapy.[4][14]
- Exercise for persistent symptoms: encourage a sustainable program selected according to preferences, ability, cost, and access. No single exercise type is consistently superior. Programs providing at least 20 cumulative hours over 8–12 weeks have been recommended for chronic pain; the program should be individualized.[1][6] Early supervised exercise is usually unnecessary for uncomplicated acute pain but may be considered when recovery is slow or the risk of poor recovery is high. This distinction does not alter advice to remain active.[2]
- Psychological support: cognitive behavioral approaches may support coping and function in persistent pain. Their use does not imply that symptoms are imaginary.[6][15]
- Adjunctive treatments: recommendations differ by guideline and symptom duration. ACP includes acupuncture among options for acute or subacute pain, whereas NICE recommends against offering acupuncture for low back pain. WHO makes conditional recommendations in favor of needling therapies, spinal manipulation, and massage for chronic primary low back pain. Discuss adjuncts as optional components of care rather than cures.[4][13][15]
Medications
Medicines are optional and generally provide small average benefits. For acute or subacute pain, ACP lists NSAIDs or skeletal muscle relaxants as options when medication is desired.[4] For chronic pain, medication should be considered when recommended nonpharmacologic treatment has not produced improvement; NSAIDs are the first-line pharmacologic option.[4][1]
- NSAIDs: explain gastrointestinal, renal, and cardiovascular risks, including new or worsening hypertension and heart failure. Use the lowest effective dose for the shortest duration, with particular caution in older adults and people with kidney or cardiovascular disease.[6][16]
- Pregnancy: avoid NSAIDs from approximately 20 weeks of gestation unless specifically directed by a clinician because of fetal renal dysfunction and oligohydramnios.[17] Avoid use at approximately 30 weeks and later because of the additional risk of premature closure of the fetal ductus arteriosus.[17][16]
- Skeletal muscle relaxants: ACP lists these as an option for selected acute presentations, but adverse events are increased. WHO makes a conditional recommendation against their use for chronic primary low back pain. Explain this distinction before discussing treatment options.[4][18][15]
- Acetaminophen: acetaminophen alone is no more effective than placebo for acute low back pain, based on high-certainty evidence. WHO makes no recommendation on acetaminophen for chronic primary low back pain; this should not be interpreted as evidence of benefit.[18][15]
- Opioids: do not present opioids as routine escalation. For acute low back pain, nonopioid therapies are at least as effective as opioids; nonopioid and nonpharmacologic approaches are preferred for subacute and chronic pain.[19] NICE recommends against opioids for chronic low back pain, and WHO makes a conditional recommendation against them for chronic primary low back pain.[13][15] ACP lists tramadol as a second-line pharmacologic option and advises considering other opioids only after recommended treatments have failed, when expected benefits outweigh risks, and after discussing known risks and realistic benefits.[4] If an opioid is prescribed for an acute episode, discuss the expected short duration and avoidance of unintended long-term use.[19]
- Other medicines for chronic pain: guidelines disagree. ACP lists duloxetine or tramadol as second-line options when NSAIDs are ineffective, with a weak recommendation based on moderate-quality evidence. Tramadol carries opioid-associated risks, including misuse.[4][19] NICE recommends against antidepressants for low back pain, while WHO conditionally recommends against SNRIs and tricyclic antidepressants for chronic primary low back pain; these positions reflect concern that small benefits are outweighed by adverse effects. WHO also conditionally recommends against anticonvulsants and glucocorticoids for chronic primary low back pain.[13][15][1] These recommendations concern treatment of back pain and do not determine treatment of separate comorbid conditions. Detailed guideline comparisons are addressed in the medical therapy microchapter.
Discussing recovery and prognosis
Substantial improvement in acute pain commonly occurs during the first 6 weeks. In inception-cohort evidence summarized in the review, mean pain decreased from approximately 56 to 26 on a 0–100 scale by 6 weeks. Approximately 72% of patients with acute pain and 42% with chronic pain recovered within 12 months. These are group estimates, dependent on study definitions of recovery, rather than individual predictions.[1] Failure to improve after about 1 month warrants clinical reassessment.[7]
Symptoms commonly fluctuate. A temporary increase during activity does not necessarily represent new injury.[1] In a prospective cohort, bending, lifting, twisting, pushing or pulling, and squatting were associated with short-term flares but not with functional limitation at 1 year. This observational finding does not establish that every activity is harmless in every patient.[20] Reassurance should include clear instructions about symptoms requiring reassessment.[7][8]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 Cashin AG, Chou R, Weimer MB, McAuley JH (2026). "Low Back Pain: A Review". JAMA. PMID 42295944 Check
|pmid=value (help). - ↑ 2.0 2.1 2.2 2.3 Foster NE, Anema JR, Cherkin D; et al. (2018). "Prevention and Treatment of Low Back Pain: Evidence, Challenges, and Promising Directions". Lancet. 391 (10137): 2368–2383. doi:10.1016/S0140-6736(18)30489-6.
- ↑ Zaina F, Côté P, Cancelliere C; et al. (2023). "A Systematic Review of Clinical Practice Guidelines for Persons With Non-Specific Low Back Pain With and Without Radiculopathy: Identification of Best Evidence for Rehabilitation to Develop the WHO's Package of Interventions for Rehabilitation". Archives of Physical Medicine and Rehabilitation. 104 (11): 1913–1927. doi:10.1016/j.apmr.2023.02.022.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Qaseem A, Wilt TJ, McLean RM; et al. (2017). "Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians". Annals of Internal Medicine. 166 (7): 514–530. doi:10.7326/M16-2367.
- ↑ Traeger AC, Hübscher M, Henschke N; et al. (2015). "Effect of Primary Care–Based Education on Reassurance in Patients With Acute Low Back Pain: Systematic Review and Meta-analysis". JAMA Internal Medicine. 175 (5): 733–743. doi:10.1001/jamainternmed.2015.0217.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Chiarotto A, Koes BW (2022). "Nonspecific Low Back Pain". The New England Journal of Medicine. 386 (18): 1732–1740. doi:10.1056/NEJMcp2032396.
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 Earwood JS, Doles NA, Russell RS. Acute Low Back Pain: Diagnosis and Management. American Family Physician. November 2025.
- ↑ 8.0 8.1 8.2 8.3 Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain. 2022. Full guideline.
- ↑ Hennessy O, Devitt AT, Synnott K, Timlin M (2025). "Assessment and early investigation of cauda equina syndrome- a systematic review of existing international guidelines and summary of the current evidence". European Spine Journal. 34 (4).
- ↑ Wood L, Dunstan E, Karouni F; et al. (2024). "Can clinical presentation predict radiologically confirmed cauda equina syndrome: retrospective case review of 530 cases at a tertiary emergency department". European Spine Journal. 33 (11): 4243–4252. doi:10.1007/s00586-024-08474-5.
- ↑ Expert Panel on Neurological Imaging, Hutchins TA, Peckham M; et al. (2021). "ACR Appropriateness Criteria® Low Back Pain: 2021 Update". Journal of the American College of Radiology. 18 (11S): S361–S379. doi:10.1016/j.jacr.2021.08.002.
- ↑ Brinjikji W, Luetmer PH, Comstock B; et al. (2015). "Systematic Literature Review of Imaging Features of Spinal Degeneration in Asymptomatic Populations". AJNR American Journal of Neuroradiology. 36 (4): 811–816. doi:10.3174/ajnr.A4173. PMID 25430861.
- ↑ 13.0 13.1 13.2 13.3 13.4 National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management. NICE guideline NG59. 2016; updated 2020. NICE NG59.
- ↑ Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP (2021). "Low Back Pain". Lancet. 398 (10294): 78–92. doi:10.1016/S0140-6736(21)00733-9.
- ↑ 15.0 15.1 15.2 15.3 15.4 15.5 World Health Organization. WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings. Geneva: WHO; 2023. WHO guideline.
- ↑ 16.0 16.1 U.S. Food and Drug Administration. Prescription NSAID class labeling and medication guides: gastrointestinal, cardiovascular, and renal warnings. Product-specific prescribing information is available through DailyMed.
- ↑ 17.0 17.1 U.S. Food and Drug Administration. FDA recommends avoiding the use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. Drug Safety Communication. October 2020.
- ↑ 18.0 18.1 Cashin AG, Wand BM, O'Connell NE; et al. (2023). "Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews". Cochrane Database of Systematic Reviews (4). doi:10.1002/14651858.CD013815.pub2.
- ↑ 19.0 19.1 19.2 Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R (2022). "CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022". MMWR Recommendations and Reports. 71 (3): 1–95. doi:10.15585/mmwr.rr7103a1.
- ↑ Suri P, Timmons AKI, Korpak AM; et al. (2025). "Transient and Long-Term Risks of Common Physical Activities in People With Low Back Pain". JAMA Network Open. 8 (12): e2547915. doi:10.1001/jamanetworkopen.2025.47915.